Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma

Clinical trial NCT07535762 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07535762
Sponsor: Shanghai Jiao Tong University School of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Peripheral T-Cell Lymphoma (PTCL NOS)Nodal T-follicular Helper Cell Lymphoma Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative)

Start date: 2026-03-30
Primary completion: 2027-12-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.